Jukka Jolkkonen Selected Research

Nitroblue Tetrazolium

5/2005	Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopiclone.
3/2005	Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury.
1/2005	Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jukka Jolkkonen Research Topics

Disease

45	Stroke (Strokes) 10/2022 - 01/2003
19	Brain Ischemia (Cerebral Ischemia) 10/2022 - 01/2000
14	Infarction (Infarctions) 10/2022 - 11/2002
12	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2015 - 11/2002
11	Ischemia 10/2022 - 01/2000
7	Ischemic Stroke 01/2021 - 02/2007
5	Brain Injuries (Brain Injury) 11/2011 - 03/2005
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 11/2011
3	Alzheimer Disease (Alzheimer's Disease) 11/2012 - 01/2009
2	Inflammation (Inflammations) 01/2017 - 09/2011
1	Encephalitis (Encephalitis, Rasmussen) 10/2022
1	Neuroinflammatory Diseases 10/2022
1	Epilepsy (Aura) 01/2022
1	Hypertension (High Blood Pressure) 01/2020
1	Hyperglycemia 01/2019
1	Intracranial Embolism 10/2017
1	Brain Edema (Cerebral Edema) 01/2017
1	Gliosis 10/2013
1	Amyloid Plaque 02/2008
1	Hyperalgesia 01/2008
1	Edema (Dropsy) 11/2007
1	Hemorrhage 11/2007

Drug/Important Bio-Agent (IBA)

11	salicylhydroxamic acid (SHAM)IBA 06/2020 - 01/2002
7	Endothelin-1 (Endothelin 1)IBA 10/2022 - 11/2006
6	Peptides (Polypeptides)IBA 02/2016 - 02/2008
6	Proteins (Proteins, Gene)FDA Link 01/2013 - 07/2005
5	Amyloid (Amyloid Fibrils)IBA 10/2013 - 07/2009
5	CalciumIBA 10/2013 - 02/2008
5	Amyloid beta-PeptidesIBA 07/2009 - 07/2005
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2011
4	Fluoxetine (Prozac)FDA LinkGeneric 02/2016 - 01/2000
3	SynaptophysinIBA 01/2019 - 06/2013
3	Nitroblue TetrazoliumIBA 05/2005 - 01/2005
2	Neuroprotective AgentsIBA 01/2021 - 02/2007
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	Glial Fibrillary Acidic ProteinIBA 01/2019 - 10/2013
2	Biological ProductsIBA 08/2017 - 01/2017
2	biotinylated dextran amine (B-DA)IBA 01/2014 - 06/2013
2	Glyburide (Glibenclamide)FDA LinkGeneric 07/2013 - 03/2013
2	Bepridil (Vascor)FDA Link 01/2013 - 11/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2012 - 01/2009
2	IronIBA 02/2008 - 11/2007
2	Diazepam (Valium)FDA LinkGeneric 05/2005 - 11/2002
2	atipamezoleIBA 02/2003 - 01/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2022
1	Meropenem (Merrem)FDA LinkGeneric 10/2022
1	Metronidazole (Metric)FDA LinkGeneric 10/2022
1	Ciprofloxacin (Cipro)FDA LinkGeneric 10/2022
1	Vancomycin FDA LinkGeneric 10/2022
1	Ampicillin (Omnipen)FDA LinkGeneric 10/2022
1	Volatile Fatty AcidsIBA 10/2022
1	CytokinesIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2019
1	CollagenIBA 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Integrin alpha4beta1 (VLA-4)IBA 10/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2017
1	IntegrinsIBA 10/2017
1	SymportersIBA 01/2017
1	ChloridesIBA 01/2017
1	Bumetanide (Bumex)FDA LinkGeneric 01/2017
1	Drinking WaterIBA 02/2016
1	plerixafor FDA Link 01/2015
1	Sodium-Calcium ExchangerIBA 09/2014
1	2- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA 09/2014
1	isoquinolineIBA 01/2014
1	Bromodeoxyuridine (BrdU)IBA 01/2014
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2014
1	SulfonamidesIBA 01/2014
1	Adenosine Monophosphate (AMP)IBA 01/2014
1	rho-Associated KinasesIBA 06/2013
1	Nogo ReceptorsIBA 06/2013
1	Chemokine CXCL12IBA 01/2013
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	traferminIBA 03/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2012
1	tau Proteins (tau Protein)IBA 11/2011
1	Ibuprofen (Motrin)FDA LinkGeneric 09/2011
1	EnzymesIBA 07/2009
1	ZincIBA 02/2008
1	CopperIBA 02/2008
1	RolipramIBA 01/2008
1	Phosphodiesterase 4 InhibitorsIBA 01/2008
1	Rose BengalIBA 11/2007
1	ferric ferrocyanide (Prussian blue)FDA Link 11/2007

Therapy/Procedure

18	Therapeutics 01/2022 - 04/2003
9	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2021 - 01/2009
2	Transplantation 10/2017 - 02/2009
2	Drug Therapy (Chemotherapy) 03/2012 - 01/2008
1	Secondary Prevention 01/2022
1	Immunomodulation 02/2021
1	Thrombectomy 01/2021
1	Stroke Rehabilitation 01/2018
1	Intra-Arterial Infusions 01/2013
1	Stem Cell Transplantation 02/2009
1	Polypharmacy 01/2008
1	Aftercare (After-Treatment) 01/2008